INTRODUCTION
In vertebrates, mature oocytes await fertilization when they are arrested at metaphase of meiosis 11. This resting state depends on the cytostatic factor (CSF), which maintains the anaphasepromoting complex/cyclosome (APc/C)-a ubiquitin E3 ligasein an inactive state (Maller et aI, 2002) . Active APc/C together with its cofactor cell division cycle 20 (Cdc20; APC/C cd C20) targets the anaphase inhibitor securin and the Cdk1 (cyclin-dependent kinase 1 )-activating cyclin B for proteasome-dependent destruction resulting in exit from meiosis. Recently, XErp1/Emi2 was identified as the molecular nature of CSF in Xenopus eggs that directly inhibits the APc/C (Schmidt et aI, 2005; Tung et aI, 2005) . Fertilization of the egg causes the activation of calmodulin/ calcium-dependent kinase 11 (CaMKII) . CaMKII, together with Polo-like kinase 1 (Plx1), then targets XErp1 for degradation, resulting in APc/C activation and the consequent completion of meiosis 11 (Uu & Maller, 2005; Rauh et ai, 2005) . The activity of iDepartment of Molecular Genetics, University of Konstanz, Universitatsstrasse 10, 78457 Konstanz, Germany ZDepartment of Genetics, University of Bayreuth, UniversiHitsstrasse 30, 95440 Bayreuth, Germany 'These authors contributed equally to this work +Corresponding author. Tel: + 49 7531 883707; Fax: + 49 7531 884036; E-mail: thomas.u.mayer@uni-konstanz.de XErpl during CSF arrest is negatively regulated by Cdk1 and positively controlled by p90
RSK kinase (Nishiyama et aI, 2007; Wu et aI, 2007a, b) . Specifically, phosphorylation of XErp1 by Cdk1 decreases both its half-life and its affinity for the APC/C. These phosphorylations are removed by the protein phosphatase 2A, which binds to XErp1 upon phosphorylation of XErpl by p90
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Thus, by alternate activation of APc/C or CSF (XErp1), these cybernetic mechanisms ensure constant Cdk1 activity at metaphase 11, despite continuous cyclin B synthesis.
A similar mechanism controls the association between Cdc20 and components of the spindle assembly checkpoint (SAC) by a dynamic balance of ubiquitylation and deubiquitylation. Activation of the SAC by unattached kinetochores leads to the association of Cdc20 with the SAC proteins Mad2 and BubR1, which prevent Cdc20 from activating the APc/C. Addition of the E2 enzyme UbcH 10 to SAC-arrested cell extract triggers the APc/ CCdc2°-dependent multi-ubiquitylation of Cdc20, and possibly other components of the APC/C-Cdc20-SAC complex, resulting in the release of Mad2 and BubR1 from Cdc20 (Reddy et ai, 2007;  Ge et ai, 2009) . Although in checkpoint arrest conditions this ubiquitylation reaction is antagonized by the activity of the ubiquitin hydrolase USP44 (Stegmeier et aI, 2007) , it rapidly activates APc/C in a switch-like manner as soon as the last kinetochore is properly attached. In this study, we show that ectopic UbcX-the Xenopus orthologue of UbcHlO (Yu et aI, 1996) -induces release from CSF arrest. In the presence of elevated levels of active UbcX, XErp1 is ubiquitylated and dissociated from the APc/C, suggesting that the APC/C inhibitory activity of XErp1 in CSF arrest can be modulated in an UbcX-dependent manner.
RESULTS AND DISCUSSION
The finding that the APC/C can liberate itself from inhibition by the SAC prompted us to test whether a similar mechanism controls CSF activity. First, we analysed whether UbcX can suppress SAC activity in Xenopus egg extract. Reportedly, egg extract with an artificially high ratio of nucleus to cytoplasm activates the SAC on treatment with spindle poisons (Minshull et aI, 1994) . We consistently observed that in vitro translated 35S-labelled securin (3sS-securin) remained stable when calcium was added to the extract containing high concentrations of sperm nuclei and nocodazole (Fig 1 A, panel 1) . Western blot analyses showed that calcium triggered XErp1 destruction, demonstrating that APc/C inhibition was maintained by SAC activity, but not by CSF activity (Fig 1 A, panel 1) . Importantly, addition of wild-type UbcX (UbcXwl), but not the catalytically inactive form (UbcXci), to SAC-arrested extract induced the destruction of 35S-securin (Fig 1 A) , suggesting that the mechanism of UbcH 1 O-mediated SAC inactivation is conserved between humans and Xenopus.
Next, we analysed whether recombinant Ubcxwt is able to release CSF arrest. Addition of calcium to CSF extract caused the degradation of XErp1, 35S-securin and cyclin B2 and the consequent decondensation of chromatin (Fig 1 B,C) . Intriguingly, Ubcxwt, but not UbcXci, triggered calcium-independent exit from meiosis, as indicated by UbcXwt-mediated destruction of APc/C substrates and chromatin decondensation (Fig 1 B,C) . Notably, in these conditions XErp1 was dephosphorylated but not degraded on exit from meiosis, as indicated by the shift in its electrophoretic mobility, suggesting that Ubcxwt neutralizes CSF activity by a different means than XErp1 degradation. Like UbcX, catalytically active UbcH10 triggered premature CSF release (supplementary Fig 51 A on line) , demonstrating that UbcX and UbcH10 are equivalent in their ability to override the CSF arrest.
In conditions in which the SAC is active, ubiquitylation of Cdc20 is antagonized by the ubiquitin hydrolase USP44 (Stegmeier et aI, 2007) . However, we could not deplete USP44 from CSF extract using any of the three antibodies we raised against Xenopus USP44, or efficiently inhibit hydrolases in CSF extract using ubiquitin aldehyde, a competitive pan-ubiquitin hydrolase inhibitor (Hershko & Rose, 1987 ; data not shown). Therefore, for technical reasons, we were not able to determine whether USP44 is involved in the regulation of CSF arrest. To exclude the possibility that the UbcXWI-induced CSF release was due to an unspecified overload of the system, we analysed the amount of Ubcxwt required for this release. Quantitative western blot analyses determined the concentration of endogenous UbcX in CSF extract to be approximately 0.8 J.lM (Fig 1 D) . Titration experiments showed that a twofold excess of Ubcxwt (approximately 1.6 J.lM) was sufficient to trigger partial destabilization of 35S-securin, whereas efficient APc/C activation was mediated by an eightfold excess of Ubcxwt (Fig 1 E) . To further analyse whether elevated levels of UbcX interfere with the function of XErp1 during meiotic progression of Xenopus oocytes, we injected recombinant Ubcxwt into stage VI oocytes and induced meiotic maturation by progesterone treatment. Consistent with the idea that the APc/C-'inhibitory function of XErp1 is essential for the transition from meiosis I to meiosis 11 (Ohe et aI, 2007) , we observed that injection of Ubcxwt into oocytes prevented entry into meiosis 11, as indicated by the failure to reaccumulate cyclin B2 after meiosis I (Fig 1 F) . In summary, these data-together with the observation that Ubcxci did not affect the CSF arrest ( Fig 2B) -demonstrate that the APc/C-inhibitory activity of XErp1 is sensitive to subtle changes in E2 activity.
As Ubcxwt/UbcHlO wt triggered CSF release but not XErp1 destruction, we investigated whether APc/C activity is required for the exit from meiosis, by Cdc20 immunodepletion (Fig 2A) . As expected, addition of calcium to Cdc20-depleted extract did not induce 35S-securin destruction (Fig 2B) . Similarly, addition of UbcHlO to the extract depleted of Cdc20 or the core APc/Csubunit Cdc27 did not mediate 35S-securin degradation (Fig 2B,C) . Add-back of recombinant Cdc20 confirmed the specificity of the Cdc20 depletion ( supplementary Fig 51 C,D online) . Thus, although ectopic E2 enzyme does not destabilize XErp1, APC/Ccdc2°-dependent ubiquitylation is still essential for this calcium-independent abrogation of the meiosis 11 arrest.
. Recently, the model that suggests that the APc/C can liberate itself from SAC inhibition has been challenged. Specifically, it has been postulated that in the presence of Mad2/BubR1/Bub3, Cdc20 is turned into an APC/C substrate resulting in its ubiquitylation and degradation (Nilsson et aI, 2008) . Thus, although the 'activation model' proposes that ubiquitylation of Cdc20 results in APc/C activation, the 'inactivation model' proposes that it induces Cdc20 degradation, that is, APc/C inactivation. In support of the latter, it has been reported that budding yeast Cdc20 is destabilized in response to SAC activation (Pan & Chen, 2004; King et aI, 2007) .
The controversy about these models prompted us to determine whether CSF arrest is mediated by the destabilization of Cdc20. As shown in Fig 3A, inhibition of protein synthesis by cycloheximide (CHX) did not significantly reduce Cdc20 levels in CSF extract. To corroborate this finding, we analysed the levels of Cdc20 when protein destruction was blocked. Addition of MG262 to CSF extract did not affect Cdc20 levels (Fig 3B) , but it completely inhibited calcium-induced degradation of cyclin B (data not shown) confirming efficient inhibition of the proteasome by MG262. Thus, Xenopus Cdc20 is not a short-lived protein in egg extract. Moreover, as CH X-treated extract was able to trigger calcium-induced degradation of cyclin B (Fig 3A) , our data demonstrate that Cdc20 levels are sufficient to effectively target APc/C substrates for destruction even when its resynthesis is inhibited. These results-together with our observation that exogenous UbcX induces premature CSF release, rather than an enhancement of the arrest-indicate that a stable CSF state is not aided by the destabilization of Cdc20.
Next, we addressed the mechanism of UbcXlUbcH 1 O-mediated CSF release. As addition of these E2 enzymes did not induce XErpl destruction, we investigated whether UbcHlO WI interferes with the APc/C-inhibitory function of XErp1. First, we used sedimentation velocity centrifugation to analyse the interaction between XErpl and the APc/C in extract. Consistent with their effect on the CSF arrest, UbcH10 wl but not UbcHl0 ci caused the dissociation of XErpl from the APc/C (Fig 3C) . To investigate more directly whether UbcHl0 wt affects the interaction between XErpl and the APc/C, we analysed the amount of XErpl coprecipitating with Cdc27 from the extract treated with UbcHlO and MG262 to prevent exit from meiosis. Intriguingly, a significantly reduced amount of XErpl was detected when Cdc27 was purified from the extract supplemented with UbcH10
Wl than from the extract containing control buffer or UbcHlO ci (Fig 3E) . Equal amounts of XErp1 in the input samples confirmed that this effect was due to reduced binding of XErp1 to the APc/C (Fig 3D) . In summary, addition of UbcHlO\vt causes premature CSF release, by interfering with the ability of XErp1 to bind to the APc/C. Elevated levels of UbcHl0 drive SAC inactivation by APc/Cdependent ubiquitylation of Cdc20 or other components of the APC/C-Cdc20 checkpoint complex (Reddy et aI, 2007) . However, when we affinity-purified Cdc20 from CSF extract supplemented with Ubcxwt, no slower-migrating forms of Cdc20, indicative of ubiquitylated Cdc20, could be detected (Fig 4A) . By contrast, a smear characteristic of ubiquitylation was detected when XErpl was immunopurified from UbcXwt-containing ex.tract (Fig 4B) . Consistent with its inability to cause premature CSF release, UbCxci did not change the electrophoretic mobility of XErpl (Fig 4B) . To confirm that ubiquitylation accounts for the highmolecular smear, we used his-tagged ubiquitin (his-Ub) to affinity-purify ubiquitylated proteins from CSF extract. Denaturing conditions during purification ensured that only proteins that were covalently attached to his-Ub were purified. As a control, CSF extract was supplemented with a truncated version of his-Ub (his-UbAGG) that was unable to form isopeptide bonds with substrates. As shown in Fig 4C, XErpl was ubiquitylated in a reaction dependent on active UbcX and conjugatable His-Ub wt . As shown in Fig 4D,E , depletion of Cdc27 but not P-TRCP (transduction repeat-containing protein) abrogated the Ubcxwt_ mediated ubiquitylation of XErpl, demonstrating that this reaction required APClC activity but not SCFP-TRCP activity. To test this directly, we performed in vitro ubiquitylation assays using immunopurified APClC. Addition of Ubcxwt but not UbCXci to immunopurified APC/C caused significant ubiquitylation of XErpl (Fig 4F) . Notably, we observed a small UbcXwt-dependent increase in slower-migrating forms of Cdc20, indicating that the APClC-associated fraction of Cdc20 is ubiquitylated by UbcX (Fig 4G) . Importantly, when we performed ill vitro APClCubiquitylation assays using active UbcXwt, and then separated the APClC-bound fraction from the supernatant, we observed the dissociation of ubiquitylated forms of XErpl from the APClC ( Fig  4F) . Efficient dissociation of XErpl was not detected when immunopurified APClC was incubated with UbCXci ( Fig 4F) . (C) CSF extracts were incubated with buffer, UbcHlOwt or UbcHIO d and centrifuged through glycerol gradients. Fractions were taken from high (fraction 3) to low (fraction 21) glycerol concentrations. Cdc27 and XErpl were detected by WB. (D) CSF extracts containing MG262 were treated as described in (C) and Cdc27 was immunoprecipitated. The immunoprecipitates were subjected to CIP phosphatase treatment and Cdc27 and XErpl were detected by WB analysis. (E) Quantification of (D). The integrated intensities of Cdc27 and XErpl signals were measured and the ratio of the signals of XErpl to Cdc27 was calculated. Buffer control was arbitrarily set to 100. APC/C, anaphase-promoting complex/cyclosome; Cdc, cell division cycle; CHX, cycloheximide; ci, catalytically inactive; CIP, calf intestinal alkaline phosphatase; CSF, cytostatic factor; lP, immunoprecipitation; WB, western blotting; wt, wild type.
Collectively, these data suggest that UbcX triggers the ubiquitylation of XErp1 and, to a lesser extent, the ubiquitylation of Cdc20, resulting in the dissociation of the APc/C inhibitor XErp1 from the APc/C Thus, our studies identify a new mechanism for regulation of XErp1 activity in Xenopus egg extract. On fertilization, CaMKII and Plx1 cooperate to neutralize XErp1 activity by targeting it for rapid, SCFP-TRcP-dependent destruction resulting in the irreversible exit from meiosis. During CSF arrest, continuous cyclin B synthesis (Yamamoto et ai, 2005) is compensated for by transient Cdk1-dependent inactivation of XErp1. Here, we show that the APc/C can liberate itself from inhibition by CSF. Specifically, we observed that increasing the activity of the APc/C-cooperating E2 enzyme UbcX causes both the ubiquitylation of XErp1 and the dissociation of XErp1 from the APc/C, suggesting that the APC/C-mediated attachment of ubiquitin to XErp1 reduces its affinity for the APc/C Although future studies are required to identify the acceptor lysine residue, the different consequences of APC/CCdc20_ and SCFP-TRcP-mediated ubiquitylation of XErp1 suggest that the two processes must differ in either the site of ubiquitin attachment or the type of ubiquitin linkages. Intriguingly, although we were unable to detect ubiquitylated Cdc20 in UbcXwt-supplemented CSF extract, our in vitro APc/C assays showed that Ubcxwt is able to ubiquitylate Cdc20, albeit inefficiently, indicating that only a small fraction of Cdc20 is modified and/or ubiquitylated Cdc20 is an efficient substrate of ubiquitin hydrolases. Thus, although we cannot rule out that the ubiquitylation of Cdc20 in addition to the one of XErp1 contributes to the reduced affinity of XErp1 for the APC/CCdc20, our data exclude the possibility that CSF-arrest is mediated by the destabilization of Cdc20. This conclusion is made on the basis of the observations that neither inhibition of protein translation or protein degradation detectably affected Cdc20 levels in CSF extract and, in conditions in which Cdc20 resynthesis is inhibited, the amount of Cdc20 in the extract is sufficient to mediate the destruction of APc/C substrates on calcium stimulus. As the second APc/C activator, Cdh 1, is not expressed in Xenopus egg extract (Lorca et ai, 1998) , the proteolysis of APc/C substrates must be mediated by Cdc20.
Our studies show that UbcX levels increase at the transition from meiosis I to meiosis 11 (supplementary Fig Sl B online) , but remain constant during meiosis 11. Thus, it is tempting to speculate that the sudden increase in UbcX activity results in partial APc/C activation, resulting in exit from meiosis I. According to this hypothesis, the delayed accumulation of XErp1 (supplementary· Fig Sl B online) would reestablish APc/C inhibition, thus preventing entry into interphase and, finally, resulting in metaphase 11-arrested mature eggs. As we have no evidence that UbcX is activated on fertilization, we favour the model that calciuminduced degradation of XErp1 is the initial trigger that partly activates the APc/C, which enables UbcX to facilitate the dissociation of XErp1 from the APc/C This model implies that the robust, yet, rapidly switchable CSF arrest is mediated by a dynamic association of XErp1 with the APc/C, and that UbcXmediated ubiquitylation helps to shift the balance towards the APC/C-unbound form of XErp1. Although under CSF arrest this mechanism would not be sufficient to result in APC/C activation, it could support the activation of the APc/C once fertilization induces the destruction of XErp1. Thus, the UbcX-mediated dissociation of XErp1 from the APc/C could provide a positivefeedback loop that contributes to an abrupt switch-like onset of anaphase on fertilization. In somatic cells, attempts of the APc/C to escape checkpoint inhibition in the presence of malattached chromosomes are constantly antagonized by the deubiquitylation of Cdc20 (Stegmeier et ai, 2007) . To fully understand how APc/C activity is regulated in CSF arrest, a future aim will be to identify the pathway that antagonizes UbcX-mediated ubiquitylation of XErp1.
METHODS
Plasmids. UbcH10 and UbcX were amplified from complementary DNA. Catalytically inactive forms were generated by mutating Cys 114.
Cytostatic factor extracts were prepared as described previously (Murray, 1991) . When indicated, CaCI 2 was added to a concentration of 600 flM, CHX to 350 flM, MG262 to 100 flM and nocodazole to 33 flM. 'High' and 'Iow' sperm extracts contained 1.2 x 10 7 and 1 x 10 6 sperm nuclei per ml extract, respectively. His-tagged UbcHlO wt !ci and Ubcxwt!ci were added to a final concentration of 12 and 6 flM, respectively. Proteins were dephosphorylated in 1 x calf intestinal alkaline phosphatase (ClP) buffer with 10 U of CIP (NEB).
Xenopus oocytes were obtained, cultured and injected as described previously (Ohe et ai, 2007) . Oocytes were homogenized in 1 x CIP buffer with 10 U of ClP (New England Biolabs) and complete protease inhibitors (Roche). Immunodepletion experiments and purification of ubiquitin conjugates were performed as described (Glockzin et ai, 2003; Schmidt et ai, 2005) .
In vitro ubiquitylation assays were carried out as described previously (Schmidt et ai, 2005) . To assay the ubiquitylation and release of XErp1 from the APC/C, magnetic beads were separated from the supernatant. 
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Fig 41 UbcXw, promotes XErpl ubiquitylation. (A) CSF extract incubated with buffer, UbcXw, or Ubcxci for 30 min was processed for WB analysis (input) or used to IP Cdc20, followed by WB analysis. (B) CSF extract was treated as in (A) and XErpl was immunoprecipitated and analysed by WB. (C) CSF extracts containing his-Ub"" or his-Ubt.GG were treated as in (A) and his-ubiquitin-modified proteins were purified with Nj2+NTA beads under denaturating conditions (his-PD). XErpl was detected by WB. (D) CSF extract that was depleted of Cdc27 or control-depleted extract was supplemented with the indicated reagent. Samples were taken and Cdc27 and XErpl were detected by WB analysis (input), or XErpl was immunoprecipitated and analysed by WB. (E) P-TRCP or control-depleted CSF extract was treated with UbcXwt and processed for WB analysis (input) or used to IP XErpl, followed by WB for XErpl. (F) APC/C was immunoprecipitated from CSF extract using magnetic beads coated with Cdc27 antibodies and treated with Ubcxwt or UbcXci for the indicated times. Then, the APC/C was removed from the reaction by the recapture of the beads and XErpl in the supernatant was detected by WB. (G) APC/C was immunoprecipitated and treated as in (F) and the reactions were analysed by WB for Cdc20 at the indicated timepoints. Note: Samples in A, B, D and E were subjected to CIP phosphatase treatment before WB analysis. Arrowheads indicate modified XErpl. APC/C, anaphase-promoting complex/cycJosome; Cdc, cell division cycle; ci, catalytically inactive; CIP, calf intestinal alkaline phosphatase; CSF, cytostatic factor; his_Ubt.GG, his-ubiquitint.GG; his-Ubwt, his-ubiquitin; lP, immunoprecipitation; PD, pull-down; Ub, ubiquitin; WB, western blotting; wt, wild type; XErpl-Ub, ubiquitin-modified XErpl.
